
Paul E. Zarek
Examiner (ID: 18450)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1617, 1628, 4161 |
| Total Applications | 773 |
| Issued Applications | 369 |
| Pending Applications | 1 |
| Abandoned Applications | 407 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8398500
[patent_doc_number] => 08268884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/521425
[patent_app_country] => US
[patent_app_date] => 2007-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16337
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12521425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521425 | Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors | Feb 4, 2007 | Issued |
Array
(
[id] => 7687406
[patent_doc_number] => 20090176885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-09
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/162397
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13611
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20090176885.pdf
[firstpage_image] =>[orig_patent_app_number] => 12162397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/162397 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | Jan 31, 2007 | Abandoned |
Array
(
[id] => 8398508
[patent_doc_number] => 08268889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Treatment of ovarian cancer'
[patent_app_type] => utility
[patent_app_number] => 12/223676
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4941
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12223676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/223676 | Treatment of ovarian cancer | Jan 31, 2007 | Issued |
Array
(
[id] => 8257735
[patent_doc_number] => 08207213
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Benzoisoindole derivatives for the treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 12/278013
[patent_app_country] => US
[patent_app_date] => 2007-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15414
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12278013
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/278013 | Benzoisoindole derivatives for the treatment of pain | Jan 31, 2007 | Issued |
Array
(
[id] => 5237284
[patent_doc_number] => 20070129441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'PROTECTION OF CELLS FROM ADVERSE EXTERNAL OR INTRINSIC EFFECTS, CELLULAR DEGENERATION AND DEATH BY N-ACYLETHANOLAMINES'
[patent_app_type] => utility
[patent_app_number] => 11/621377
[patent_app_country] => US
[patent_app_date] => 2007-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8667
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11621377
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/621377 | PROTECTION OF CELLS FROM ADVERSE EXTERNAL OR INTRINSIC EFFECTS, CELLULAR DEGENERATION AND DEATH BY N-ACYLETHANOLAMINES | Jan 8, 2007 | Abandoned |
Array
(
[id] => 5410723
[patent_doc_number] => 20090124622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'Medicament Containing a Thiazole Derivative as an Active Ingredient'
[patent_app_type] => utility
[patent_app_number] => 12/227162
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6466
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124622.pdf
[firstpage_image] =>[orig_patent_app_number] => 12227162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/227162 | Medicament Containing a Thiazole Derivative as an Active Ingredient | Dec 21, 2006 | Abandoned |
Array
(
[id] => 7688780
[patent_doc_number] => 20070105918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/614528
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8802
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11614528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/614528 | Use of Pramipexole to Treat Amyotrophic Lateral Sclerosis | Dec 20, 2006 | Abandoned |
Array
(
[id] => 5586070
[patent_doc_number] => 20090105272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Prodrugs of modulators of ABC transporters'
[patent_app_type] => utility
[patent_app_number] => 11/643634
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19259
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105272.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643634 | Prodrugs of modulators of ABC transporters | Dec 20, 2006 | Abandoned |
Array
(
[id] => 5258799
[patent_doc_number] => 20070212431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Cream for treatment of skin injured by the sun'
[patent_app_type] => utility
[patent_app_number] => 11/642948
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2771
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212431.pdf
[firstpage_image] =>[orig_patent_app_number] => 11642948
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/642948 | Cream for treatment of skin injured by the sun | Dec 20, 2006 | Abandoned |
Array
(
[id] => 7688737
[patent_doc_number] => 20070105961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => '1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/643129
[patent_app_country] => US
[patent_app_date] => 2006-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6709
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11643129
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/643129 | 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists | Dec 20, 2006 | Abandoned |
Array
(
[id] => 5220267
[patent_doc_number] => 20070161578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist'
[patent_app_type] => utility
[patent_app_number] => 11/641527
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31605
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161578.pdf
[firstpage_image] =>[orig_patent_app_number] => 11641527
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/641527 | Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and/or H3 receptor antagonist/inverse agonist | Dec 18, 2006 | Abandoned |
Array
(
[id] => 5423039
[patent_doc_number] => 20090149495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/158580
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7937
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20090149495.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158580
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158580 | COMPOUNDS | Dec 18, 2006 | Abandoned |
Array
(
[id] => 5558794
[patent_doc_number] => 20090270371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/158596
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13990
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270371.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158596
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158596 | QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS | Dec 18, 2006 | Abandoned |
Array
(
[id] => 8932731
[patent_doc_number] => 08492431
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-23
[patent_title] => 'Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity'
[patent_app_type] => utility
[patent_app_number] => 11/611938
[patent_app_country] => US
[patent_app_date] => 2006-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14198
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11611938
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/611938 | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity | Dec 17, 2006 | Issued |
Array
(
[id] => 5120622
[patent_doc_number] => 20070142337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Treatment of inflammation and organ dysfunction'
[patent_app_type] => utility
[patent_app_number] => 11/638432
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13173
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638432 | Treatment of inflammation and organ dysfunction | Dec 13, 2006 | Abandoned |
Array
(
[id] => 5035379
[patent_doc_number] => 20070099918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy'
[patent_app_type] => utility
[patent_app_number] => 11/609407
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5722
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11609407
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/609407 | Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy | Dec 11, 2006 | Abandoned |
Array
(
[id] => 5231475
[patent_doc_number] => 20070293583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => 'Use of low-dose ladostigil for neuroprotection'
[patent_app_type] => utility
[patent_app_number] => 11/637600
[patent_app_country] => US
[patent_app_date] => 2006-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13069
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293583.pdf
[firstpage_image] =>[orig_patent_app_number] => 11637600
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/637600 | Use of low-dose ladostigil for neuroprotection | Dec 10, 2006 | Issued |
Array
(
[id] => 5022144
[patent_doc_number] => 20070148110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Aqueous-alcoholic depigmenting gels comprising mequinol and adapalene'
[patent_app_type] => utility
[patent_app_number] => 11/636432
[patent_app_country] => US
[patent_app_date] => 2006-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5813
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148110.pdf
[firstpage_image] =>[orig_patent_app_number] => 11636432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/636432 | Aqueous-alcoholic depigmenting gels comprising mequinol and adapalene | Dec 10, 2006 | Abandoned |
Array
(
[id] => 4760004
[patent_doc_number] => 20080312230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Organic Compounds'
[patent_app_type] => utility
[patent_app_number] => 12/097326
[patent_app_country] => US
[patent_app_date] => 2006-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22998
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312230.pdf
[firstpage_image] =>[orig_patent_app_number] => 12097326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/097326 | Organic Compounds | Dec 10, 2006 | Abandoned |
Array
(
[id] => 5035310
[patent_doc_number] => 20070099849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents'
[patent_app_type] => utility
[patent_app_number] => 11/608276
[patent_app_country] => US
[patent_app_date] => 2006-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14079
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20070099849.pdf
[firstpage_image] =>[orig_patent_app_number] => 11608276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/608276 | Co-Therapy for the Treatment of Migraine Comprising Anticonvulsant Derivatives and Anti-Migraine Agents | Dec 7, 2006 | Abandoned |